Clinical Trials on Non-hematologic Malignancies
Total 31142 results
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis... and other collaboratorsTerminated
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Non-hematologic MalignanciesUnited States, Canada
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
Tel-Aviv Sourasky Medical CenterMeir Medical Center; Max Planck Institute for Infection BiologyUnknownPediatric Solid Malignancies | Pediatric Hematological MalignanciesIsrael
-
Astellas Pharma Global Development, Inc.TerminatedNon-hematologic Malignancies | Pharmacokinetics of ASP9853United States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Centre Hospitalier Universitaire de BesanconTerminatedHematological Malignancies BFrance
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
AstraZenecaParexelCompletedSolid and Hematological MalignanciesGermany
-
Medical College of WisconsinCompletedMalignancies, HematologicUnited States
-
University of California, DavisCompletedHematologic MalignanciesUnited States
-
AdaptimmuneTerminatedSolid and Hematological MalignanciesUnited States, Canada
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.AvailableRelapsed and Refractory Hematological MalignanciesChina
-
Shandong UniversityJuventas Cell Therapy Ltd.UnknownRelapsed or Refractory Hematological MalignanciesChina
-
CASI Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hematological MalignanciesCanada
-
He HuangYake Biotechnology Ltd.RecruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingAdvanced Solid Tumors and Hematological Malignancies
-
He HuangGracell Biotechnology Ltd.Not yet recruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineWithdrawnLymphoid Hematological Malignancies | Umbilical Cord Blood Transplant
-
Senti BiosciencesNot yet recruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological Malignancies
-
Baptist Health South FloridaWithdrawnNon-Hodgkin Lymphoma | Hematologic Malignancy | B-Cell Lymphoid MalignanciesUnited States
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la LoireCompletedHematological Malignancies Treated With Intensive ChemotherapyFrance
-
Pharmacosmos A/SCompleted
-
Shanxi Bethune HospitalRecruitingHematological MalignancyChina
-
Institut Paoli-CalmettesSanofiNot yet recruiting
-
The Affiliated People's Hospital of Ningbo UniversityRecruitingHematological MalignancyChina
-
University of Missouri-ColumbiaRecruiting
-
Zhejiang UniversityRecruiting
-
Peking University People's HospitalSanofiRecruitingHematological MalignancyChina
-
M.D. Anderson Cancer CenterNot yet recruiting
-
Beckman Coulter, Inc.Completed
-
Fate TherapeuticsTerminatedHematological MalignancyUnited States
-
University Hospital, Strasbourg, FranceUnknownHematological MalignancyFrance
-
Universitaire Ziekenhuizen KU LeuvenInstitutul Clinic FundeniCompletedHematological MalignancyBelgium, Romania
-
University Hospital TuebingenLudwig-Maximilians - University of Munich; University Hospital AugsburgCompletedRelapse of Hematological Malignancies
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
Henry Ford Health SystemRecruitingHematological MalignancyUnited States
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
University of CopenhagenZealand University HospitalEnrolling by invitationHematological MalignancyDenmark
-
Washington University School of MedicineBarnes-Jewish HospitalTerminatedHematological MalignancyUnited States
-
Institut Paoli-CalmettesCompletedHematological MalignancyFrance
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHematological MalignancyUnited States